Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • ABOUT THE IPILOGUE
    • BLOG
      • Announcements
      • Artificial Intelligence
      • Copyright
      • Innovation
      • IP Innovation Clinic
      • IP Intensive
      • Patents
      • Privacy
      • Technology
      • Trademarks
    • IPILOGUE TEAM
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
    • WRITE FOR US
  • IP INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • THE IP LUNCH CLUB
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • CONTESTS & COMPETITIONS
    • 2021 Oxford International Intellectual Property Law Moot
    • WIPO Short Story Competition: Indigenous Ingenuity and Creativity
    • IP WRITING CHALLENGE
    Home
    >
    sean jackson

    Tag: sean jackson

    March 26, 2013in Canada, Feature Post, IP, Jurisdiction0by Editor
    1342

    Reflecting On A Day Of Discussions Surrounding The Important Student Role From Invention To Commercialization

    On March 22, 2013, IP Osgoode and the Canadian Intellectual Property Office (CIPO) co-hosted a conference examining the role of student researchers in commercializing intellectual property. Inspired by her SSHRC-funded…

    Read more
    January 22, 2013in Canada, Feature Post, IP, IP Intensive, Patent Practice, Patents0by Editor
    1266

    The Teva Experience: A Semester in Osgoode's IP Intensive Program

    As part of Osgoode’s Intellectual Property Law Intensive Program, I had the opportunity to spend ten weeks at Teva Canada working with in-house counsel. Teva Canada is one of Canada’s largest generic pharmaceutical…

    Read more
    November 22, 2012in IP Intensive, Patent Practice, Patents, Pharmaceutical Drugs1by Editor
    2032

    Subsequent Entry Biologic Litigation Set to Take Off in Canada

    The Canadian pharmaceutical industry is entering a new era as Subsequent Entry Biologic (SEB) litigation begins to emerge in the Canadian pharmaceutical landscape. Biologic drugs are derived through the metabolic…

    Read more
    November 9, 2012in Access to Medicines, Canada, Feature Post, IP, Patents, Pharmaceutical Drugs1by Editor
    637

    Canada’s Top Court Gives Canadians Something to Get Excited About, Generic Viagra!

    On November 8, 2012 the Supreme Court of Canada (SCC) released its eagerly anticipated decision in the “Viagra Appeal”. In a unanimous decision written by Justice LeBel, the SCC found…

    Read more
    April 15, 2012in Patent Practice, Patents, Pharmaceutical Drugs4by Editor
    1955

    Disclosure Front and Centre as Pfizer Prepares to Defend Viagra in Supreme Court of Canada

    This Wednesday, April 18, Pfizer will defend the patent protecting the little blue pill that has changed the lives of men and women around the world.  The pill is of…

    Read more
    April 6, 2012in Access to Medicines, European Union, Feature Post, IP, Patents, Pharmaceutical Drugs2by Editor
    1870

    Should Canada Strengthen IP Protection for Pharmaceutical Products? The European Union Thinks So...

    The Canadian government and European Union (EU) are currently negotiating a Comprehensive Economic and Trade Agreement (CETA).  A key issue has been ensuring that Canadian intellectual property rights for pharmaceutical…

    Read more

    Posts navigation

    1 2
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736